24-10-2024 |
AH |
|
DXCM |
DexCom, Inc. |
29,290 |
0.45 |
0.43 |
0.50 |
DexCom Non-GAAP EPS of $0.45 beats by $0.02, revenue of $994.2M beats by $3.01M [10/24/2024 4:05 PM] |
73.58 |
-1.27 (-1.69%) |
72.86 |
-1.99 (-2.66%) |
62.34 - 142.00 |
12,758,187 |
4,550,000 |
493,532 |
|
|
25-07-2024 |
AH |
|
DXCM |
DexCom, Inc. |
44,590 |
0.43 |
0.39 |
0.34 |
DexCom Non-GAAP EPS of $0.43 beats by $0.04, revenue of $1B misses by $40M [7/25/2024 4:06 PM] |
63.92 |
-43.93 (-40.73%) |
65.32 |
-42.53 (-39.43%) |
62.34 - 142.00 |
48,471,943 |
3,360,000 |
2,680,708 |
|
|
25-04-2024 |
AH |
|
DXCM |
DexCom, Inc. |
51,660 |
0.32 |
0.27 |
0.17 |
DexCom Non-GAAP EPS of $0.32 beats by $0.05, revenue of $921M beats by $10.1M [4/25/2024 4:05 PM] |
124.41 |
-13.60 (-9.85%) |
132.32 |
-5.69 (-4.12%) |
74.75 - 142.00 |
6,967,453 |
2,780,000 |
23,070 |
|
|
08-02-2024 |
AH |
|
DXCM |
DexCom, Inc. |
48,270 |
0.50 |
0.43 |
0.34 |
DexCom beats top-line and bottom-line estimates; reaffirms FY24 outlook [2/8/2024 4:14 PM] |
120.55 |
-6.50 (-5.12%) |
123.40 |
-3.65 (-2.87%) |
74.75 - 139.55 |
5,031,693 |
2,790,000 |
15,611 |
|
|
26-10-2023 |
AH |
|
DXCM |
DexCom, Inc. |
33,490 |
0.50 |
0.34 |
0.28 |
DexCom Non-GAAP EPS of $0.50 beats by $0.17, revenue of $975M beats by $37.38M [10/26/2023 4:04 PM] |
89.29 |
8.20 (10.11%) |
92.96 |
11.87 (14.64%) |
74.75 - 139.55 |
12,783,514 |
5,410,000 |
229,830 |
|
|
27-07-2023 |
AH |
|
DXCM |
DexCom, Inc. |
49,510 |
0.34 |
0.22 |
0.17 |
DexCom Non-GAAP EPS of $0.34 beats by $0.11, revenue of $871.3M beats by $30.35M [7/27/2023 4:05 PM] |
132.46 |
3.10 (2.40%) |
134.36 |
5.00 (3.87%) |
77.51 - 139.55 |
4,329,384 |
3,100,000 |
59,095 |
|
|
27-04-2023 |
AH |
4:00 PM ET (Apr 27) |
DXCM |
DexCom, Inc. |
48,050 |
0.17 |
0.15 |
0.08 |
DexCom Non-GAAP EPS of $0.17 beats by $0.02, revenue of $741.5M beats by $20.98M [4/27/2023 4:05 PM] |
121.60 |
-1.98 (-1.60%) |
118.51 |
-5.07 (-4.10%) |
66.89 - 126.44 |
3,288,916 |
2,230,000 |
23,266 |
|
|
09-02-2023 |
AH |
4:00 PM ET (Feb 9) |
DXCM |
DexCom, Inc. |
42,300 |
0.34 |
0.26 |
0.17 |
DexCom Non-GAAP EPS of $0.34 beats by $0.06, revenue of $815.2M in-line [2/9/2023 4:08 PM] |
117.82 |
10.58 (9.87%) |
112.46 |
5.22 (4.87%) |
66.89 - 134.76 |
5,724,634 |
2,460,000 |
5,081 |
|
|
27-10-2022 |
AH |
4:00 PM ET (Oct 27) |
DXCM |
DexCom, Inc. |
39,330 |
0.28 |
0.24 |
0.22 |
DexCom Non-GAAP EPS of $0.28 beats by $0.04, revenue of $769.6M beats by $18.56M [10/27/2022 4:05 PM] |
121.08 |
19.83 (19.59%) |
114.06 |
12.81 (12.65%) |
66.89 - 164.86 |
8,266,432 |
2,760,000 |
21,921 |
|
|
28-07-2022 |
AH |
4:00 PM ET (Jul 28) |
DXCM |
DexCom, Inc. |
32,880 |
0.17 |
0.16 |
0.19 |
DexCom Non-GAAP EPS of $0.17 misses by $0.02, revenue of $696.2M misses by $13.13M [7/28/2022 4:09 PM] |
82.07 |
-4.92 (-5.66%) |
79.00 |
-7.99 (-9.18%) |
66.89 - 164.86 |
9,026,883 |
2,370,000 |
161,582 |
|
|
28-04-2022 |
AH |
4:00 PM ET (Apr 28) |
DXCM |
DexCom, Inc. |
41,560 |
0.32 |
0.50 |
0.33 |
DexCom Non-GAAP EPS of $0.32 misses by $0.20, revenue of $628.8M beats by $4.83M [4/28/2022 4:20 PM] |
407.74 |
-5.49 (-1.33%) |
397.00 |
-16.23 (-3.93%) |
318.45 - 659.45 |
1,149,199 |
600,000 |
6,522 |
|
|
10-02-2022 |
AH |
4:00 PM ET (Feb 10) |
DXCM |
DexCom, Inc. |
41,240 |
0.68 |
0.86 |
0.91 |
DexCom Non-GAAP EPS of $0.68 misses by $0.17, revenue of $698.2M in-line [2/10/2022 4:04 PM] |
420.81 |
-21.46 (-4.85%) |
426.00 |
-16.27 (-3.68%) |
318.45 - 659.45 |
937,837 |
850,000 |
20,197 |
|
|
28-10-2021 |
AH |
4:00 PM ET (Oct 28) |
DXCM |
DexCom, Inc. |
54,730 |
0.89 |
0.62 |
0.94 |
DexCom EPS beats by $0.24, beats on revenue [10/28/2021 4:06 PM] |
624.05 |
53.73 (9.42%) |
573.00 |
2.68 (0.47%) |
305.63 - 627.96 |
1,102,119 |
440,000 |
4,378 |
|
|
29-07-2021 |
AH |
4:00 PM ET (Jul 29) |
DXCM |
DexCom, Inc. |
43,380 |
0.76 |
0.43 |
0.79 |
DexCom EPS beats by $0.32, beats on revenue [7/29/2021 4:04 PM] |
515.62 |
59.58 (13.06%) |
475.00 |
18.95 (4.16%) |
305.63 - 524.31 |
2,243,384 |
570,000 |
12,621 |
|
|
29-04-2021 |
AH |
4:00 PM ET (Apr 29) |
DXCM |
DexCom, Inc. |
40,500 |
0.33 |
0.31 |
0.44 |
DexCom EPS beats by $0.04, beats on revenue [4/29/2021 4:07 PM] |
385.72 |
-35.98 (-8.53%) |
400.00 |
-21.70 (-5.15%) |
305.63 - 456.23 |
2,529,358 |
600,000 |
3,951 |
|
|
11-02-2021 |
AH |
4:00 PM ET (Feb 11) |
DXCM |
DexCom, Inc. |
38,730 |
0.91 |
0.91 |
1.15 |
DexCom EPS misses by $0.01, beats on revenue [2/11/2021 4:03 PM] |
411.74 |
1.54 (0.38%) |
387.78 |
-22.42 (-5.47%) |
182.07 - 456.23 |
1,796,106 |
778,993 |
5,693 |
|
|
27-10-2020 |
AH |
4:00 PM ET (Oct 27) |
DXCM |
DexCom, Inc. |
39,350 |
0.94 |
0.64 |
0.65 |
DexCom EPS beats by $0.28, beats on revenue [10/27/2020 4:10 PM] |
349.87 |
-30.76 (-8.08%) |
368.50 |
-12.13 (-3.19%) |
147.52 - 456.23 |
5,367,338 |
976,759 |
6,464 |
|
|
28-07-2020 |
AH |
4:00 PM ET (Jul 28) |
DXCM |
DexCom, Inc. |
39,930 |
0.79 |
0.31 |
0.08 |
DexCom EPS beats by $0.44, beats on revenue [7/28/2020 4:05 PM] |
420.62 |
2.83 (0.68%) |
431.33 |
13.54 (3.24%) |
138.28 - 446.50 |
1,177,561 |
730,795 |
11,089 |
|
|